trial · primary record
Lumateperone
Schizophrenia
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 300 |
| Primary completion | 2032-04-28 |
| Primary endpoint | Incidence of Common Adverse Events |
| Registry ID | NCT06229210 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:39.153Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06229210
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Lumateperone · compound